DE69011861D1 - Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. - Google Patents

Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Info

Publication number
DE69011861D1
DE69011861D1 DE69011861T DE69011861T DE69011861D1 DE 69011861 D1 DE69011861 D1 DE 69011861D1 DE 69011861 T DE69011861 T DE 69011861T DE 69011861 T DE69011861 T DE 69011861T DE 69011861 D1 DE69011861 D1 DE 69011861D1
Authority
DE
Germany
Prior art keywords
effect
active substances
substances added
msh4
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69011861T
Other languages
English (en)
Other versions
DE69011861T2 (de
Inventor
David Peter Page-Thomas
David Roy Bard
Clive Graham Knight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898914527A external-priority patent/GB8914527D0/en
Priority claimed from GB909007469A external-priority patent/GB9007469D0/en
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Application granted granted Critical
Publication of DE69011861D1 publication Critical patent/DE69011861D1/de
Publication of DE69011861T2 publication Critical patent/DE69011861T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69011861T 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. Expired - Fee Related DE69011861T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898914527A GB8914527D0 (en) 1989-06-23 1989-06-23 Targetting agents
GB909007469A GB9007469D0 (en) 1990-04-03 1990-04-03 Targetting agents
PCT/GB1990/000966 WO1991000111A1 (en) 1989-06-23 1990-06-22 Targetting agents

Publications (2)

Publication Number Publication Date
DE69011861D1 true DE69011861D1 (de) 1994-09-29
DE69011861T2 DE69011861T2 (de) 1995-02-16

Family

ID=26295539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69011861T Expired - Fee Related DE69011861T2 (de) 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Country Status (9)

Country Link
EP (1) EP0478631B1 (de)
JP (1) JPH04506343A (de)
AT (1) ATE110280T1 (de)
AU (1) AU636365B2 (de)
DE (1) DE69011861T2 (de)
DK (1) DK0478631T3 (de)
ES (1) ES2057572T3 (de)
NZ (1) NZ234173A (de)
WO (1) WO1991000111A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68913753T2 (de) * 1988-10-04 1994-08-11 Cancer Res Campaign Tech Zielmittel.
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
AU709012B2 (en) * 1994-11-17 1999-08-19 Amgen, Inc. Stable N-terminally linked DTPA:protein compositions and methods
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
US8123747B2 (en) 2007-08-16 2012-02-28 Nutek Orthopaedics, Inc. Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means
US8262657B2 (en) 2007-08-16 2012-09-11 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means and convergent bone pins
US7717916B2 (en) 2007-08-16 2010-05-18 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means
US8603435B2 (en) 2008-01-10 2013-12-10 Stc.Unm Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
KR100999044B1 (ko) 2008-03-26 2010-12-09 한국원자력연구원 킬레이트제 접합 α-ＭＳＨ 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물

Also Published As

Publication number Publication date
NZ234173A (en) 1993-10-26
WO1991000111A1 (en) 1991-01-10
AU636365B2 (en) 1993-04-29
EP0478631A1 (de) 1992-04-08
DK0478631T3 (da) 1995-04-10
ES2057572T3 (es) 1994-10-16
DE69011861T2 (de) 1995-02-16
EP0478631B1 (de) 1994-08-24
ATE110280T1 (de) 1994-09-15
AU5839190A (en) 1991-01-17
JPH04506343A (ja) 1992-11-05

Similar Documents

Publication Publication Date Title
DE68912302D1 (de) Härtendes material für medizinischen und dentalen gebrauch.
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
ATE106898T1 (de) Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
ATE192339T1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69524864D1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
DK0573551T3 (da) Serinrige peptidlinkere
BR9403783A (pt) Uso de uma composição cosmética
DE69011861D1 (de) Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DE68928975D1 (de) Aushärtender Werkstoff für ärztlichen und zahnärztlichen Gebrauch
IT1224000B (it) Composizione e procedimento per il trattamento e la cura dei capelli
BR9007115A (pt) Novo trombolitico
DE59100496D1 (de) Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen.
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
FR2651682B1 (fr) Appareil destine a la destruction des varices des membres inferieurs chez l'homme.
IT1283025B1 (it) Macchina da cucire perfezionata per uso industriale in grado di ese- guire due cuciture in sequenza immediata, con la possibilita' di vari-
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee